BioCentury | Sep 12, 2018
Politics & Policy

China biopharma stocks fall after centralized tendering talks

...Shanghai:600196; HKEX:2196) lost RMB1.09 to RMB28 in Shanghai and HK$2.30 to HK$27.55 in Hong Kong; Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Aug 17, 2018
Financial News

Blackstone investing $400M in Chinese company HEC

...and senior management. HEC lost HK$2.60 to HK$33.70 on Aug. 15. Yichang HEC Changjiang Pharmaceutical Co. Ltd. (HKSE:1558), Yichang, China Chris Lieu Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Aug 15, 2018
Financial News

Blackstone investing $400M in Chinese company HEC

..."Safety, Trade Concerns Weigh on China Biotechs" ). HEC lost HK$2.60 to HK$33.70 on Wednesday. Chris Lieu Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Nov 11, 2016
Company News

HEC, TaiGen deal

...TaiGen’s TaiGen BioPharmaceuticals Co. subsidiary and HEC’s YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558, Gongguan, China) will establish an unnamed newco...
BioCentury | Oct 31, 2016
Company News

TaiGen, HEC launch cross-strait newco for HCV combo

...TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157) and the YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558) subsidiary of HEC Pharm Group (Dongguan, China...
Items per page:
1 - 5 of 5
BioCentury | Sep 12, 2018
Politics & Policy

China biopharma stocks fall after centralized tendering talks

...Shanghai:600196; HKEX:2196) lost RMB1.09 to RMB28 in Shanghai and HK$2.30 to HK$27.55 in Hong Kong; Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Aug 17, 2018
Financial News

Blackstone investing $400M in Chinese company HEC

...and senior management. HEC lost HK$2.60 to HK$33.70 on Aug. 15. Yichang HEC Changjiang Pharmaceutical Co. Ltd. (HKSE:1558), Yichang, China Chris Lieu Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Aug 15, 2018
Financial News

Blackstone investing $400M in Chinese company HEC

..."Safety, Trade Concerns Weigh on China Biotechs" ). HEC lost HK$2.60 to HK$33.70 on Wednesday. Chris Lieu Yichang HEC Changjiang Pharmaceutical Co. Ltd....
BioCentury | Nov 11, 2016
Company News

HEC, TaiGen deal

...TaiGen’s TaiGen BioPharmaceuticals Co. subsidiary and HEC’s YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558, Gongguan, China) will establish an unnamed newco...
BioCentury | Oct 31, 2016
Company News

TaiGen, HEC launch cross-strait newco for HCV combo

...TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157) and the YiChang HEC ChangJiang Pharmaceutical Co. Ltd. (HKSE:1558) subsidiary of HEC Pharm Group (Dongguan, China...
Items per page:
1 - 5 of 5